Twinbeech Capital LP Penumbra Inc Transaction History

Twinbeech Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $14.9 Million - $18.5 Million	67,759 New	67,759 $15.1 Million
Q2 2022 Aug 15, 2022	SELL	$116.09 - $227.33 $412,119 - $807,021	-3,550 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$187.51 - $283.98 $665,660 - $1.01 Million	3,550 New	3,550 $789,000
Q4 2021 Feb 14, 2022	SELL	$238.08 - $288.0 $327,598 - $396,288	-1,376 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$250.72 - $291.24 $344,990 - $400,746	1,376 New	1,376 $367,000
Q2 2021 Aug 16, 2021	SELL	$235.0 - $310.7 $587,030 - $776,128	-2,498 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$175.6 - $291.43 $159,093 - $264,035	-906 Reduced 26.62%	2,498 $676,000
Q4 2020 Feb 16, 2021	BUY	$174.98 - $272.83 $595,631 - $928,713	3,404 New	3,404 $596,000

383

29.3M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.89B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.